Mike Birch

1.4k total citations
38 papers, 1.1k citations indexed

About

Mike Birch is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Mike Birch has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 15 papers in Molecular Biology and 14 papers in Epidemiology. Recurrent topics in Mike Birch's work include Antifungal resistance and susceptibility (27 papers), Fungal Infections and Studies (13 papers) and Biochemical and Molecular Research (5 papers). Mike Birch is often cited by papers focused on Antifungal resistance and susceptibility (27 papers), Fungal Infections and Studies (13 papers) and Biochemical and Molecular Research (5 papers). Mike Birch collaborates with scholars based in United Kingdom, United States and Austria. Mike Birch's co-authors include David W. Denning, Jason D. Oliver, D. Law, Michael Bromley, Derek Law, Nicola Beckmann, Graham E. M. Sibley, Saskia du Pré, Joanne Livermore and G. D. Robson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Mike Birch

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Birch United Kingdom 21 754 571 224 200 166 38 1.1k
Jennifer Nielsen Kahn United States 20 696 0.9× 458 0.8× 225 1.0× 194 1.0× 132 0.8× 28 1.1k
Katsura Hata Japan 10 705 0.9× 596 1.0× 166 0.7× 134 0.7× 113 0.7× 17 916
Taylor R. T. Dagenais United States 10 669 0.9× 492 0.9× 427 1.9× 338 1.7× 177 1.1× 11 1.3k
J P Debeaupuis France 15 735 1.0× 433 0.8× 394 1.8× 438 2.2× 217 1.3× 24 1.3k
Derek Law United States 13 619 0.8× 497 0.9× 98 0.4× 76 0.4× 105 0.6× 17 716
Kelley R. Healey United States 16 988 1.3× 809 1.4× 174 0.8× 192 1.0× 120 0.7× 25 1.1k
Rasmus Krøger Hare Denmark 27 1.4k 1.8× 1.3k 2.3× 138 0.6× 246 1.2× 471 2.8× 47 1.8k
Montserrat Ortoneda Spain 17 444 0.6× 398 0.7× 92 0.4× 187 0.9× 280 1.7× 21 766
Henrich A. L. van der Lee Netherlands 8 687 0.9× 477 0.8× 83 0.4× 171 0.9× 231 1.4× 10 821
L. Improvisi France 16 609 0.8× 643 1.1× 174 0.8× 213 1.1× 170 1.0× 24 956

Countries citing papers authored by Mike Birch

Since Specialization
Citations

This map shows the geographic impact of Mike Birch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Birch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Birch more than expected).

Fields of papers citing papers by Mike Birch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Birch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Birch. The network helps show where Mike Birch may publish in the future.

Co-authorship network of co-authors of Mike Birch

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Birch. A scholar is included among the top collaborators of Mike Birch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Birch. Mike Birch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliver, Jason D., et al.. (2025). In vitro evaluation of olorofim and antifungal combinations against Aspergillus and Candida species. Journal of Antimicrobial Chemotherapy. 80(11). 3139–3149. 1 indexed citations
2.
Halliday, Catriona, Enoch Tay, Wendy Green, et al.. (2024). In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020–2023. Journal of Antimicrobial Chemotherapy. 79(10). 2611–2621. 11 indexed citations
3.
Rhijn, Norman van, et al.. (2023). Aspergillus fumigatus strains that evolve resistance to the agrochemical fungicide ipflufenoquin in vitro are also resistant to olorofim. Nature Microbiology. 9(1). 29–34. 34 indexed citations
4.
Nunnally, Natalie S., et al.. (2023). In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans. Microbiology Spectrum. 11(1). e0278922–e0278922. 12 indexed citations
5.
Levine, Tim P., et al.. (2023). Characterisation of putative class 1A DHODH-like proteins from Mucorales and dematiaceous mould species. PLoS ONE. 18(8). e0289441–e0289441. 8 indexed citations
6.
Houbraken, Jos, et al.. (2023). Novel Antifungals and Aspergillus Section Terrei with Potpourri Susceptibility Profiles to Conventional Antifungals. Journal of Fungi. 9(6). 649–649. 3 indexed citations
8.
Oliver, Jason D., Danny Tuckwell, Joanne Livermore, et al.. (2012). The Aspergillus fumigatus Dihydroxyacid Dehydratase Ilv3A/IlvC Is Required for Full Virulence. PLoS ONE. 7(9). e43559–e43559. 29 indexed citations
9.
Carr, Paul D., Danny Tuckwell, Christophe d’Enfert, et al.. (2010). The Transposon impala Is Activated by Low Temperatures: Use of a Controlled Transposition System To Identify Genes Critical for Viability of Aspergillus fumigatus. Eukaryotic Cell. 9(3). 438–448. 26 indexed citations
10.
Bromley, Michael, et al.. (2010). Functional analysis of a mitochondrial phosphopantetheinyl transferase (PPTase) gene pptB in Aspergillus fumigatus. Fungal Genetics and Biology. 48(4). 456–464. 23 indexed citations
11.
Robson, Geoff, et al.. (2007). Characterisation of Aft1 a Fot1/Pogo type transposon of Aspergillus fumigatus. Fungal Genetics and Biology. 45(2). 117–126. 19 indexed citations
12.
Tuckwell, Danny, et al.. (2006). Two families of extracellular phospholipase C genes are present in aspergilli. Mycological Research. 110(10). 1140–1151. 8 indexed citations
13.
Birch, Mike, David W. Denning, & Geoffrey D. Robson. (2004). Comparison of extracellular phospholipase activities in clinical and environmentalAspergillus fumigatusisolates. Medical Mycology. 42(1). 81–86. 24 indexed citations
14.
Brotchie, D., Neil Roberts, Mike Birch, et al.. (1999). [28] Characterization of ocular cellular and extracellular structures using confocal microscopy and computerized three-dimensional reconstruction. Methods in enzymology on CD-ROM/Methods in enzymology. 307. 496–513. 2 indexed citations
15.
Birch, Mike & David W. Denning. (1999). Molecular Typing of Aspergillus terreus by Random Amplification of Polymorphic DNA. European Journal of Clinical Microbiology & Infectious Diseases. 18(11). 838–841. 15 indexed citations
16.
Baily, Guy, et al.. (1998). Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient. Journal of Infection. 36(1). 57–62. 11 indexed citations
17.
Birch, Mike, D.B. Drucker, Inmaculada Riba, Simon J. Gaskell, & David W. Denning. (1998). Polar lipids ofAspergillus fumigatus, A, niger, A, nidulans, A, flavusandA. terreus. Medical Mycology. 36(3). 127–134. 8 indexed citations
18.
Birch, Mike, D. Brotchie, Neil Roberts, & Ian Grierson. (1997). The Three-Dimensional Structure of the Connective Tissue in the Lamina Cribrosa of the Human Optic Nerve Head. Ophthalmologica. 211(3). 183–191. 20 indexed citations
19.
Birch, Mike, Michael J. Anderson, & David W. Denning. (1995). Molecular typing of Aspergillus species. Journal of Hospital Infection. 30. 339–351. 21 indexed citations
20.
Birch, Mike, N. Nolard, G. S. Shankland, & David W. Denning. (1995). DNA typing of epidemiologically-related isolates ofAspergillus fumigatus. Epidemiology and Infection. 114(1). 161–168. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026